Share on LinkedInShare on LinkedIn

ARTICLE · 04 SEPTEMBER 2008

Intent To Deceive Must Be Shown By Clear And Convincing Evidence

Addressing the issue of inequitable conduct during patent prosecution, the U.S. Court of Appeals for the Federal Circuit affirmed a district court’s holding that the patentee’s alleged acts did not rise to the level of inequitable conduct.

United StatesIntellectual Property
Leonid Mikityanskiy
Leonid Mikityanskiy
Author LinkedIn connections

Addressing the issue of inequitable conduct during patent prosecution, the U.S. Court of Appeals for the Federal Circuit affirmed a district court's holding that the patentee's alleged acts did not rise to the level of inequitable conduct. The court also affirmed the district court's findings of validity and infringement. Eisai Co. Ltd. and Eisai, Inc., v. Dr. Reddy's Labs. Ltd. and Dr. Reddy's Labs. Inc, and Teva Pharms. USA, Inc., Case No. 07-1397, -1398 (Fed. Cir., July 21, 2008) (Rader, C. J.).

Eisai Co., Ltd. and Eisai, Inc. (Eisai) own a patent claiming drugs for the treatment of gastrointestinal disorders. Eisai filed a suit against Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. (Dr. Reddy's) and Teva Pharmaceuticals USA, Inc. (Teva) after they filed Abbreviated New Drug Applications to market generic versions. Dr. Reddy's and Teva conceded infringement, but asserted

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from